Page 59 - ARNM-2-1

Advances in Radiotherapy
& Nuclear Medicine Symmetrical bilateral extranodal recurrence in FL

4. Conclusion Consent for publication

This paper aims to elucidate an unusual instance of The patient included in this research gave written and
skeletal muscle recurrence in a patient with a history of informed consent to publish the data contained within this
FL. It underscores the importance of radiologist vigilance study.
in identifying unexpected, inconspicuous lesions,
emphasizing that some uncommon lesions may lack Availability of data
contrast enhancement. A precise clinical classification Not applicable.
and comprehensive medical history are imperative for
discerning the necessity of additional scans. References
The combination of PET with F-FDG and CT has 1. Freedman A. Follicular lymphoma: 2018 update on diagnosis
18
become a crucial imaging modality for identifying or and management. Am. J. Hematol. 2018;93(2):296-305.
predicting high-grade transformation and/or selecting doi: 10.1002/ajh.24937
optimal biopsy sites. In this patient, 18 F-FDG PET/
CT successfully detected and localized a rare FL site, 2. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision
of the world health organization classification of lymphoid
underscoring the utility of hybrid machines like PET/CT in neoplasms. Blood. 2016;127(20):2375-2390.
providing both metabolic and morphological information
using a singular method. doi: 10.1182/blood-2016-01-643569
The staging and prognosis of newly diagnosed patients 3. Sutamtewagul G, Link BK. Novel treatment approaches
are influenced by PET. Quantitative measurements based and future perspectives in follicular lymphoma. Ther Adv
Hematol. 2019;10:204062071882051.
on the maximum standard uptake value (SUV ) provide
max
information on FDG metabolism, although the correlation doi: 10.1177/2040620718820510
between high SUV and histological transformation 4. Kaseb H, Ali MA, Koshy NV. Follicular lymphoma. In:
max
remains unclear. Positron emission tomography surpasses StatPearls. Treasure Island, FL: StatPearls Publishing; 2024.
CT in response assessment. Recent research suggests that 5. Alamdari A, Naderi N, Peiman S, Shahi F. Non-Hodgkin
PET holds promise as the gold standard imaging modality lymphoma with primary involvement of skeletal muscle. Int
for FL staging, response assessment, and restaging, 17,18 J Hematol Oncol Stem Cell Res. 2014;8:55-57.
necessitating a multidisciplinary approach for optimal 6. Glass AG, Karnell LH, Menck HR. The national cancer
patient care.
data base report on non-Hodgkin’s lymphoma. Cancer.
Acknowledgments 1997;80(12):2311-2320.
7. Cheson BD, Fisher RI, Barrington SF, et al. Recommendations
None. for initial evaluation, staging, and response assessment

Funding of hodgkin and non-hodgkin lymphoma: The lugano
classification. J Clin Oncol. 2014;32(27):3059-3068.
None. doi: 10.1200/JCO.2013.54.8800
Conflict of interest 8. Surov A. Imaging findings of skeletal muscle lymphoma.
Clin Imaging. 2014;38(5):594-598.
The authors declare that they have no competing interests.
doi: 10.1016/j.clinimag.2014.03.006
Author contributions 9. Gao S, Shu H, Yang H. Imaging features of skeletal muscle

Conceptualization: Cesare Oliveti, Giuseppe Lucio Cascini lymphoma: A case report and literature review. BMC Med
Imaging. 2021;21(1):136.
Formal analysis: Cesare Oliveti, Roberta Mancini
Investigation: Cesare Oliveti, Claudia Italia Maria De Santis doi: 10.1186/s12880-021-00667-4
Methodology: Cesare Oliveti, Barbara Catalfamo 10. Kostakoglu L, Goldsmith SJ. Fluorine-18 fluorodeoxyglucose
Writing – original draft: Cesare Oliveti, Annachiara positron emission tomography in the staging and follow-up
Mollace, Francesco Manti of lymphoma: Is it time to shift gears? Eur J Nucl Med.
Writing – review & editing: Cesare Oliveti, Giuseppe Lucio 2000;27(10):1564-1578.
Cascini doi: 10.1007/s002590000340

Ethics approval and consent to participate 11. Paes FM, Kalkanis DG, Sideras PA, Serafini AN. FDG PET/
CT of extranodal involvement in non-hodgkin lymphoma
Not applicable. and hodgkin disease. Radiographics 2010;30(1):269-291.

Volume 2 Issue 1 (2024) 4 https://doi.org/10.36922/arnm.2828